Showing the latest 10 filings. Sign in to filter or browse the full history. View full history
Showing 10 of 27 filings.
25 Aug 2026 4 filings
AGM Details
Date and time: 22 September 2026 at 12:30 PM IST.
Mode: VC/OAVM; venue deemed at registered office.
Board meeting for Notice approval on 6 August 2026.
Total resolutions: 3.
E-voting window: 19 Sep 2026 09:00 to 21 Sep 2026 17:00.
E-voting cut-off: 15 September 2026.
Results to be announced within 2 working days after AGM.
Scrutinizer & Governance
Scrutinizer: Darshika Wankhede (Practising Company Secretary).
Appointment date: 6 August 2026.
AGM date and delivery framework
43rd AGM and FY2025-26 annual report scheduled for 22 Sep 2026 at 12:30 PM via VC/OAVM.
Electronic dispatch to members with registered email; non-registered addresses will receive a physical letter.
Annual Report/Notice available at medicaps.com/investorrelation/annual-reports and BSE/CDSL portals.
Physical copy requests to investors@medicaps.com with Folio No./DP Id/Client Id.
Notice aligns with Companies Act 2013, MCA Circular No. 03/2025 and SEBI Regulations.
Letter is a draft for those without registered email; includes web link to full details.
Financial snapshot
Standalone total income: 288.24 Lakhs.
Standalone revenue from operations: 230.59 Lakhs.
Standalone EBITDA: 6.12 Lakhs.
Standalone PBT: -12.46 Lakhs.
Standalone PAT: -13.87 Lakhs.
Standalone EPS: -0.11.
Consolidated total revenue: 2065.64 Lakhs.
Consolidated PAT: -303.75 Lakhs.
Consolidated EPS: -2.44.
Dividends: no dividend declared for 2025-26.
Capital structure
Equity share capital: Rs 12.47 Crore.
Promoter stake: Alok Garg 26.21%, Manisha Garg 21.61%.
Borrowings: Nil; no debt outstanding.
Dematerialisation: 96.77% of shares.
Governance & board changes
Ramesh Chandra Mittal resigned as Chairman & Director on 06 Aug 2026.
Kusum Mittal resigned as Director on 06 Aug 2026.
Saloni Garg appointed Additional Director & Whole-Time Woman Director from 07 Aug 2026.
Alok K Garg re-appointed Chairman & Managing Director for three years from 01 Sep 2026.
Subsidiaries & related party
Medgel Private Limited is a material subsidiary; 100% holding.
Medgel turnover: 1014.26 Lakhs; investment in Medgel: 4282.35 Lakhs.
Major related party transactions include MD remuneration Rs 84.00 Lakhs; CFO remuneration Rs 30.00 Lakhs; Saloni Garg Rs 24.00 Lakhs.
End-year related party balances: MD Rs 7.00; Akshit Garg Rs 2.50; Saloni Garg Rs 2.00; Abhishek Jain Rs 0.70; Hemant Sethi Rs 1.95.
Audit, controls & compliance
Statutory auditor: Rawka & Associates; Secretarial: Joshi Sahay; Internal: Praveen Shrivastava.
Secretarial MR-3; historical charges flagged; ROC follow-up ongoing.
Internal financial controls are adequate and effective.
2023-24 penalty: Rs 5,900 for delayed related party disclosure.
Outlook & risks
Management focuses on real estate; project pipeline and prudent cost control.
Market conditions impact near-term performance; ongoing liquidity management.
Shareholder information & AGM
43rd AGM scheduled 22 Sep 2026 via VC/OAVM.
Cut-off date 15 Sep 2026; remote e-voting 19-21 Sep 2026.
Top holders: Alok Garg 26.21%, Manisha Garg 21.61%, Sangeetha S 5.55%.
AGM Details
Date/time: 22 September 2026 at 12:30 IST.
Mode: VC/OAVM; venue at registered office.
Ordinary Business
Adopt standalone financial statements for year ended 31 March 2026.
Adopt consolidated financial statements for year ended 31 March 2026.
Special Businesses
Re-appointment of Alok Garg as CMD for three years at Rs 7.00 Lakh per month.
Appointment of Saloni Garg as Whole-Time Woman Director for three years at Rs 2.00 Lakh per month.
Confirmation of Saloni Garg as Director and Whole-Time Woman Director.
Perquisites capped at 25% of annual salary.
Director Changes
Ramesh Chandra Mittal resigned as Chairman and Director on 06 Aug 2026.
Alok K Garg appointed Chairman and Managing Director from 01 Sep 2026.
Saloni Garg appointed Additional Director on 07 Aug 2026.
6 Aug 2026 3 filings
Resignations of Senior Management
Saloni Garg resigns; Senior Manager; effective 6 Aug 2026; due to appointment as Additional Director.
Akshit Garg resigns; General Manager; effective 6 Aug 2026; due to appointment as CFO and KMP.
Both resignations confirm no other material reasons beyond stated.
MD re-appointment
Re-appointment of Alok K. Garg as Chairman cum Managing Director for 01 Sep 2026–31 Aug 2029.
Subject to members' approval at the 43rd AGM.
MBA in Marketing; Diploma in Export Documentation; 26+ years' experience.
Father-in-law of Saloni Garg.
Not debarred by SEBI or authorities.
CFO appointment
Appointment of Akshit Garg as CFO and KMP effective 07 Aug 2026.
Term: Not specified.
Masters in Management and Finance from RMIT; 8+ years in Finance and Marketing.
Not debarred by SEBI or authorities.
Saloni Garg appointment
Appointment of Saloni Garg as Additional Director and Whole-Time Woman Director, w.e.f 07 Aug 2026.
Term: 3 years (07 Aug 2026–06 Aug 2029) subject to AGM.
MBA branding expertise; Graduate in Business Management from Mumbai; senior Medicaps manager.
Daughter-in-law of Alok K. Garg.
Not debarred by SEBI or authorities.
Consolidated results
Net sales for quarter ended 30 Jun 2026: ₹271.70 lakhs.
Total income: ₹283.83 lakhs.
PAT (continuing): ₹-223.29 lakhs.
EPS (continuing): ₹-1.79 (basic and diluted).
Other comprehensive income: ₹445.34 lakhs.
Total comprehensive income: ₹222.05 lakhs.
Medi-Caps Business Park shop revenue: ₹4.41 lakhs.
Medgel Private Limited included; not material to the group.
Segment performance
Pharma division revenue: ₹268.20 lakhs; PBT: ₹-164.33 lakhs.
Real estate division revenue: ₹10.49 lakhs; PBT: ₹-58.96 lakhs.
Total segment revenue: ₹278.69 lakhs; total segment PBT: ₹-223.29 lakhs.
Consolidated net sales: ₹271.70 lakhs; other income: ₹5.14 lakhs.
Board actions & AGM
Saloni Garg resigns; appointed Additional Director and Whole Time Woman Director for 3 years from 7 Aug 2026.
Akshit Garg resigns as GM; appointed CFO and KMP from 7 Aug 2026.
Alok K. Garg reappointed MD & CMD for 3 years from 1 Sep 2026.
AGM scheduled for 22 Sep 2026 at 12:30 PM via VC/OAVM.
Unaudited results to be uploaded on medicaps.com and BSE.
Auditor's review & disclosures
Limited Review concluded no material misstatement in standalone and consolidated results.
Consolidated results include Medgel Private Limited; not material to the group.
30 Jul 2026 1 filing
Director resignations
Mr. Ramesh Chandra Mittal resigns as Chairperson and Non-Executive Non-Independent Director.
Mrs. Kusum Mittal resigns as Non-Executive Non-Independent Director.
Effective from close of business on 06 August 2026.
Reason: personal health concerns for both directors.
There are no other material reasons disclosed for either resignation.
Board will consider acceptance; resignation letters to be placed at the upcoming Board meeting.
No explicit regulatory or shareholder approval mentioned for the resignations.
No committee memberships disclosed as affected by the resignations.
There are no immediate changes to board composition announced.
Resignations will be filed with ROC and BSE as applicable.